Update on consensus on diagnosis and treatment of... (2019 study) Skip to main content
Systematic Review Acta Otorrinolaringol Esp (Engl Ed) 2019

Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss

Herrera M, García Berrocal J, García Arumí A, Lavilla M, Plaza G, Acta Otorrinolaringol Esp (Engl Ed), 2019

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

A group of Spanish ear, nose and throat specialists updated a national consensus on how to diagnose, treat and follow up sudden hearing loss in one ear with no known cause.

What They Found

This systematic review of the literature from 1966 to March 2018, covering 1508 relevant papers, produced a consensus that all patients with idiopathic sudden sensorineural hearing loss should be treated with steroids, taken by mouth and/or injected into the middle ear depending on the patient. For diagnosis, the consensus lists otoscopy, acumetry, tonal audiometry, speech audiometry and tympanometry as mandatory tests to rule out conductive causes. A full analysis should be done before treatment starts, and an MRI is requested, ideally within the first 15 days after diagnosis. If systemic steroids fail, injection into the middle ear is also recommended as a rescue. Follow-up is advised at day 7 and after 12 months.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy. It describes only the diagnostic tests, steroid treatment, MRI timing and follow-up schedule recommended by a Spanish consensus for sudden hearing loss in one ear. Patients with sudden hearing loss can use this as a general picture of the work-up and steroid-based care described, and should talk with their own doctor about their situation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract itself says treatment for this condition is very controversial, and the recommendations come from a consensus process, so the abstract does not report a measured treatment effect.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 30093087
Year Published 2019
Journal Acta Otorrinolaringol Esp (Engl Ed)
MeSH Terms Adrenal Cortex Hormones; Diagnostic Techniques, Otological; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Neuroimaging; Otolaryngology; Physical Examination; Primary Health Care; Prognosis; Referral and Consultation; Salvage Therapy; Systematic Reviews as Topic

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology